Table II.
Study characteristics at age 8 years (n = 127)
| Age (y) | 7.7 (7.1-8.2) |
| Follow-up time (y) | 6.8 (6.3-7.1) |
| Followed up from patient charts | 127 (100%) |
| Attended the 7-y follow-up visit and followed up from patient charts | 73 (57) |
| Any sensitization∗ | 31/73 (42) |
| Food | 19 (26) |
| Aeroallergen | 23 (32) |
| Atopic asthma (based on specific IgE testing) | 13 |
| Nonatopic asthma (based on specific IgE testing) | 16 |
| Followed up from patient charts and parental interviews | 54 (43) |
| Only patient charts | 38 (30) |
| Allergy testing (allergen-specific IgE measurement or skin prick test) | 16 |
| Atopic asthma (based on specific IgE testing) | 3 |
| Nonatopic asthma (based on specific IgE testing) | 1 |
| Patient charts and parental interviews | 16 (13) |
| Allergy testing (allergen-specific IgE measurement or skin prick test) | 2 |
| Atopic asthma (based on specific IgE testing) | 2 |
| Atopic asthma (based on charts and questionnaires) | 1 |
| Nonatopic asthma (based on charts and questionnaires) | 1 |
| Asthma ever during follow-up | 67 (53) |
| Asthma in remission by end of follow-up | 30 (24) |
| Current asthma | 37 (29) |
| Atopic | 19 (15) |
| Nonatopic | 18 (14) |
Values are shown as medians (interquartile ranges) or numbers (percentages) of subjects.
∗
Defined as IgE antibodies to any of the common allergens. See the Methods section for details.